Factors associated with satisfaction with community-based non-medicalized counseling and testing using HIV rapid tests among MSM in France

ABSTRACT

The aims of the study were to determine the level of satisfaction of men who have sex with men (MSM) participating in two community-based non-medicalized counseling and testing programs (ANRS-DRAG and ANRS-COM’TEST) offering HIV rapid tests (hereafter CBOffer), and to identify factors associated with satisfaction. Between 2009 and 2011, 436 participants voluntarily benefited from a CBOffer in the two programs. They completed self-administered questionnaires before and after testing. Psychosocial scores were constructed using principal component analyses to reflect the following dimensions: post-test satisfaction, avoidance of at-risk situations as a HIV risk-reduction strategy, and attitudes towards condom use. Logarithmic regression of the post-test satisfaction score was performed on these scores and on other selected explanatory variables, including the variable “self-identification as homosexual or bisexual”. Post-test satisfaction ranged between 90–99 and below 90 for 50% and 25% of the participants, respectively. Post-test satisfaction with the CBOffer was independently associated with self-defined sexuality, meeting place for sexual partners, participants’ attitudes about being HIV-positive, and condom use. The very high level of satisfaction was associated with both personal and socio-behavioral factors. Vulnerable MSM could be targeted better and, accordingly, could use this offer more frequently as a combined prevention tool.

KEYWORDS:

• Rapid testing
• community-based research
• MSM
• prevention

Acknowledgements

The ANRS-DRAG study group

Dhotte P., Boo N., Fleury F., Gosset D., Jolly-Guyot P., Meiffredy V., Agulhon O., Muzas C., Teyssier V., Regimbeau M.L., Hamani A., Barbot J.M., Allion P., and Collignon A. (CDAG Figuier, Paris); Pozza D., Walfard C., Tosini W., Derouineau J., Pahlavan G., Castano F., Bohbot J.M., Sednaoui P., Roy B., Allamelou G., Boussaid S., and Chartenet A. (CDAG Fournier, Paris); Passeron A., Dekhil S., Billaut S., Barrade C., Camuso M., and Mellul S. (CDAG St Roch, Nice); Vernay-Vaisse C., Martinet P., Compagnon C., Raoux A., Labrunie V., Berthou D., Anquetil M., and Grob A. (CDAG St Adrien, Marseille); Legall J.M., Andreo C., Stranz R., Monvoisin D., Faver P., Adetchessi O., Boulanger S., Cousin G., Domergues D., Girard. T., Issa M., Labrouve V., Lacoste C., Mekhalfa D., Mommessin S., Montigny S., Petrot J.P., Roturier L., Rovera P., Saint-Laurent J., Sentenac G., Tosti D., Coquelin V., Braz G., Mazoyer S., Vivet V., Szumigalski R., Djessima-Taba A., Fournet Y., Margerie M., Margerie D., Totouom A., Descharles D., Bonvalot C., Crespo C., Mampouya B., Gasnier M., De Rigaud M., Filippi E., Bucknall S., and Moudachirou K. (AIDES); Suzan-Monti M., Préau M., Carrieri P.M., Lorente N., Fugon L., Blanche J., Sagaon-Teyssier L., and Mora M. (UMR S912, Marseille); Otis J. (UQAM, Montréal); Brenner B., and Wainberg M.A. (General Jewish Hospital, Montréal); Doré V., Lemestre S., Marchand L., Porteret I., and Couffin S. (ANRS).

Disclosure statement

No potential conflict of interest was reported by the authors.

Notes

1. Weightings for these three items were, respectively, 0.583, 0.576, and 0.556, showing their important contribution to the overall score calculated from the PCA.

Additional information

Funding

The study was supported by the French Agence Nationale de Recherche sur le Sida et les hepatitis virales (ANRS, http://www.anrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.